When is Biolife Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Biolife Sciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Biolife Sciences pay dividends?
Biolife Sciences does not currently pay dividends.
What is Biolife Sciences’s EPS estimate?
Biolife Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolife Sciences have?
Biolife Sciences has 4,829,364,000 shares outstanding.
Which hedge fund is a major shareholder of Biolife Sciences?
Currently, no hedge funds are holding shares in BLFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biolife Sciences
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.